Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Merk

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Journal of Medicinal Chemistry|January 6, 2022
Design of a Potent TLX Agonist by Rational Fragment FusionGiuseppe Faudone, Rezart Zhubi, Fatih Celik, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2024
A High-Quality Photoswitchable Probe that Selectively and Potently Regulates the Transcription Factor RORγMartin Reynders, Sabine Willems, Julian A Marschner, et al.
Journal of the American Chemical Society|November 4, 2025
<i>De Novo</i> Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI InhibitorsMaxwell Sigal, Markus Egner, Chikako Okada, et al.
Journal of Medicinal Chemistry|September 5, 2024
Development of Tailless Homologue Receptor (TLX) Agonist Chemical ToolsEmily C Hank, Minh Sai, Till Kasch, et al.
Scientific Reports|October 2, 2015
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X ReceptorJurema Schmidt, Franca-Maria Klingler, Ewgenji Proschak, et al.
Chemmedchem|September 12, 2023
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer AgonismDaniel Zaienne, Laura Isigkeit, Julian A Marschner, et al.
Journal of Medicinal Chemistry|May 31, 2023
<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia|January 13, 2021
THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODELA Stavniichuk, O Savchuk, Abdul Hye Khan, et al.
Bioorganic & Medicinal Chemistry|January 14, 2015
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligandsDaniel Merk, Christina Lamers, Julia Weber, et al.
Communications Chemistry|February 3, 2025
Chemogenomics for steroid hormone receptors (NR3)Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Journal of Medicinal Chemistry|January 6, 2022
Design of a Potent TLX Agonist by Rational Fragment FusionGiuseppe Faudone, Rezart Zhubi, Fatih Celik, et al.
Angewandte Chemie (International Ed. in English)|September 9, 2024
A High-Quality Photoswitchable Probe that Selectively and Potently Regulates the Transcription Factor RORγMartin Reynders, Sabine Willems, Julian A Marschner, et al.
Journal of the American Chemical Society|November 4, 2025
<i>De Novo</i> Discovery of α,α-Disubstituted α-amino Acid-Containing α-helical Peptides as Competitive PPARγ PPI InhibitorsMaxwell Sigal, Markus Egner, Chikako Okada, et al.
Journal of Medicinal Chemistry|September 5, 2024
Development of Tailless Homologue Receptor (TLX) Agonist Chemical ToolsEmily C Hank, Minh Sai, Till Kasch, et al.
Scientific Reports|October 2, 2015
NSAIDs Ibuprofen, Indometacin, and Diclofenac do not interact with Farnesoid X ReceptorJurema Schmidt, Franca-Maria Klingler, Ewgenji Proschak, et al.
Chemmedchem|September 12, 2023
Structural Modification of the Natural Product Valerenic Acid Tunes RXR Homodimer AgonismDaniel Zaienne, Laura Isigkeit, Julian A Marschner, et al.
Journal of Medicinal Chemistry|May 31, 2023
<i>De Novo</i> Design of Nurr1 Agonists <i>via</i> Fragment-Augmented Generative Deep Learning in Low-Data RegimeMarco Ballarotto, Sabine Willems, Tanja Stiller, et al.
Visnyk Kyivs'Koho Natsional'Noho Universytetu Imeni Tarasa Shevchenka. Biolohiia|January 13, 2021
THE EFFECT OF COMPOUND DM509 ON KIDNEY FIBROSIS IN THE CONDITIONS OF THE EXPERIMENTAL MODELA Stavniichuk, O Savchuk, Abdul Hye Khan, et al.
Bioorganic & Medicinal Chemistry|January 14, 2015
Anthranilic acid derivatives as nuclear receptor modulators--development of novel PPAR selective and dual PPAR/FXR ligandsDaniel Merk, Christina Lamers, Julia Weber, et al.
Communications Chemistry|February 3, 2025
Chemogenomics for steroid hormone receptors (NR3)Espen Schallmayer, Laura Isigkeit, Lewis Elson, et al.
Pageof 17